News Melodiol Global Health Limited

Equities

ME1

AU0000282840

Market Closed - Australian S.E. Other stock markets 02:10:55 2024-04-23 am EDT			5-day change	1st Jan Change
0.004 ^AUD	-20.00%		0.00%	-90.00%

Apr. 16	Melodiol Global's Revenue Surges 79% in Q1	MT
Apr. 09	Melodiol Global Health Subsidiary Health House Australia to Launch Medicinal Cannabis Clinic	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Melodiol Global's Revenue Surges 79% in Q1	Apr. 15	MT
Melodiol Global Health Subsidiary Health House Australia to Launch Medicinal Cannabis Clinic	Apr. 08	MT
Melodiol Global Health Posts 148% Increase in FY 2023 Revenue to AU$21.6 Million	Mar. 26	MT
Melodiol Global Health Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
Melodiol Unit to Add Cannabis Products Across Six Canadian Provinces	Feb. 13	MT
Melodial's Unit Logs AU$1 Million Revenues in January	Feb. 07	MT
Melodiol Global Health Limited Announces Resignation of Erlyn Dawson as Joint Company Secretary	Dec. 21	CI
Melodiol Global Health Limited Reports Unaudited Revenue Results for the Nine Months of 2023	Nov. 12	CI
Melodiol Global's Canadian Arm Mernova Posts Record Sales for October	Nov. 02	MT
Melodiol Global Health Achieves 80% Remission Rate from Phase Two Hallucinogenic Trial	23-10-11	MT
Melodial's Canadian Arm Mernova Logs Record Sales in Q3	23-10-10	MT
Melodiol Global Health Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-31	CI
Panacea Life Sciences Holdings, Inc. entered into a non-binding LOI to acquire Sierra Sages Herbs, LLC and Halucenex Life Sciences Inc. for $20 million.	23-08-01	CI
Melodiol Logs Strong Start to Q3 with AU$1.6 Million in Revenue and Confirmed Purchase Orders	23-07-20	MT
Melodiol Global Health Limited Announces Revenue Results for Third Quarter of 2023	23-07-18	CI
Melodiol Global Health Triples Q2 Net Sales	23-07-13	MT
Creso Pharma Changes Name to Melodiol Global Health	23-06-12	MT
Creso Pharma Signs Deal to Import Psychedelic Medication into Australia	23-06-09	MT
Creso Pharma's Subsidiary Hires Consultant to Support Licensing Process in Australia, Europe	23-06-04	MT
Creso Pharma Raises AU$2.5 Million Via Share Issue	23-05-19	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Melodiol Global Health Limited

Equities

ME1

AU0000282840

Summary

Filters